Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7851489 Pyridinone compounds

Patent 7851489 was granted and assigned to Bristol-Myers Squibb on December, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7851489

Date of Patent

December 14, 2010

Patent Application Number

11936984

Date Filed

November 8, 2007

Patent Citations Received

‌

US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor

‌

US Patent 11866434 Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof

‌

US Patent 11866451 Salts and crystalline forms of a PD-1/PD-L1 inhibitor

‌

US Patent 11873309 Heterocyclic compounds as immunomodulators

‌

US Patent 11673883 Heterocyclic compounds as immunomodulators

‌

US Patent 11753406 Salts of a PD-1/PD-L1 inhibitor

‌

US Patent 11760756 Crystalline form of a PD-1/PD-L1 inhibitor

‌

US Patent 11780836 Process of preparing a PD-1/PD-L1 inhibitor

...

Patent Primary Examiner

‌

Zinna N. Davis

Patent abstract

The invention is directed to pyridinone compounds useful for modulating Met kinase, having the following structure:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7851489 Pyridinone compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API